tenofovir has been researched along with Fatty Liver in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Krzowska-Firych, J; Pokora-Rodak, A; Tomasiewicz, K | 1 |
| Atalay, R; Ayrancı, FG; Çakmak, Ş; Doğanay, L; Özdil, K; Sayar, S; Tanboğa, İH | 1 |
| Accarino, EV; Buti, M; Chen, CH; Cheung, KS; Cheung, R; Chuang, WL; Dai, CY; Enomoto, M; Hoang, J; Hsu, YC; Huang, CF; Huang, JF; Istratescu, D; Kozuka, R; Lee, DH; Liu, L; Nguyen, MH; Peng, CY; Preda, C; Riveiro-Barciela, M; Trinh, H; Tsai, PC; Wong, GL; Wong, VW; Wu, JL; Xie, Q; Yeh, ML; Yeo, YH; Yu, ML; Yuen, MF | 1 |
| Ahn, SH; Han, KH; Jeon, MY; Kim, BK; Kim, DS; Kim, DY; Kim, SU; Lee, HW; Park, JY | 1 |
| Lee, JW; Yu, JH | 1 |
| Afdhal, N; Aguilar Schall, R; Akarca, US; Buti, M; Flaherty, JF; Flisiak, R; Jacobson, IM; Marcellin, P; McHutchison, JG; Myers, RP; Patel, K; Subramanian, GM; Tchernev, KG; Thompson, A; Washington, MK; Younossi, Z | 1 |
| Barreiro, P; Soriano, V; Tuma, P; Vispo, E | 1 |
| Bisi, L; Borghi, V; Cossarizza, A; Manzini, L; Mussini, C | 1 |
1 review(s) available for tenofovir and Fatty Liver
| Article | Year |
|---|---|
[Role of tenofovir in HIV and hepatitis C virus coinfection].
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Chemical and Drug Induced Liver Injury; Disease Progression; Drug Hypersensitivity; Drug Interactions; Drug Therapy, Combination; Fatty Liver; Glucose Metabolism Disorders; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Liver; Liver Cirrhosis; Organophosphonates; Reverse Transcriptase Inhibitors; Ribavirin; Tenofovir | 2008 |
2 trial(s) available for tenofovir and Fatty Liver
| Article | Year |
|---|---|
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.
Topics: Alanine Transaminase; Antiviral Agents; Bilirubin; China; Cohort Studies; DNA, Viral; Fatty Liver; Female; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Male; Middle Aged; Tenofovir; Treatment Outcome; Viremia | 2021 |
Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Biopsy; Clinical Trials, Phase III as Topic; Fatty Liver; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Histocytochemistry; Humans; Liver; Male; Middle Aged; Tenofovir; Young Adult | 2017 |
5 other study(ies) available for tenofovir and Fatty Liver
| Article | Year |
|---|---|
Concentration of LDLR, degree of hepatic fibrosis and hepatic steatosis in patients with chronic hepatitis B infection treated with tenofovir disoproxil fumarate.
Topics: Adult; Aged; Antiviral Agents; Fatty Liver; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lipoproteins, HDL; Liver Cirrhosis; Male; Middle Aged; Receptors, LDL; Tenofovir; Triglycerides | 2021 |
Does Hepatic Steatosis Influence the Virological Response with Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir Disoproxil Fumarate?
Topics: Adult; Antiviral Agents; DNA, Viral; Fatty Liver; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Retrospective Studies; Tenofovir; Treatment Outcome | 2022 |
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir.
Topics: Adult; Antiviral Agents; Fatty Liver; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Sustained Virologic Response; Tenofovir; Treatment Outcome | 2019 |
How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
Topics: Fatty Liver; Guanine; Hepatitis B, Chronic; Humans; Tenofovir | 2019 |
Absence of liver steatosis in HIV-HCV co-infected patients receiving regimens containing tenofovir or abacavir.
Topics: Adenine; Adult; Anti-HIV Agents; Coinfection; Dideoxynucleosides; Fatty Liver; Female; Genotype; Hepatitis C; HIV Infections; Humans; Liver; Male; Multivariate Analysis; Organophosphonates; Prevalence; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Tenofovir | 2013 |